Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313174911> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W2313174911 endingPage "853" @default.
- W2313174911 startingPage "853.1" @default.
- W2313174911 abstract "<h3>Background</h3> Tocilizumab is an inhibitor of the IL-6 receptor and is highly efficient in the treatment of rheumatoid arthritis. Leucopenia has been observed in 10% of the patients, which has been partly attributed to concomitant methotrexate therapy, but may also occur in monotherapy with tocilizumab. The pathomechanism of the leucopenia remains unclear. <h3>Objectives</h3> To study the influence of tocilizumab on the function and on apoptosis of neutrophils. <h3>Methods</h3> Granulocytes from the peripheral blood of 13 healthy controls were incubated overnight with medium only or with medium containing various concentrations between 0.8 and 800 μg/ml of tocilizumab. The concentrations were chosen based on the recommended dose of tocilizumab of 8 mg/kg. The apoptosis rate of the granulocytes was studied by Annexin-V/7-AAD staining using flow cytometry. In addition, the surface expression of the cell adhesion receptor CD11b, the chemokine receptors CD181 and CD182 and of CD62L, indicating an enhanced migration capacity, were measured. The adhesion of granulocytes to a layer of human vascular endothelial cells (HUVEC) after 1 hour of incubation was studied by harvesting and counting non-bound cells. <h3>Results</h3> Tocilizumab was found to bind to neutrophils. The treatment of neutrophils with tocilizumab slightly reduced the expression of CD62L at the highest dose studied and almost doubled the adhesion to HUVEC in vitro in the whole dose range. The rate of apoptosis and of cell survival was not affected. <h3>Conclusions</h3> Neutropenia during treatment with tocilizumab appears to be a consequence of enhanced cell adhesion to endothelia and presumably migration rather than of apoptosis and cell death. <h3>Acknowledgements</h3> Chugai Pharma Marketing Ltd for financial support of the study. <h3>Disclosure of Interest</h3> None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.2660" @default.
- W2313174911 created "2016-06-24" @default.
- W2313174911 creator A5011519841 @default.
- W2313174911 creator A5020516419 @default.
- W2313174911 creator A5034871851 @default.
- W2313174911 creator A5043705577 @default.
- W2313174911 creator A5086542581 @default.
- W2313174911 date "2014-06-01" @default.
- W2313174911 modified "2023-09-23" @default.
- W2313174911 title "AB0150 Tocilizumab Does not Induce Apoptosis in Neutrophils in Vitro" @default.
- W2313174911 doi "https://doi.org/10.1136/annrheumdis-2014-eular.2660" @default.
- W2313174911 hasPublicationYear "2014" @default.
- W2313174911 type Work @default.
- W2313174911 sameAs 2313174911 @default.
- W2313174911 citedByCount "0" @default.
- W2313174911 crossrefType "journal-article" @default.
- W2313174911 hasAuthorship W2313174911A5011519841 @default.
- W2313174911 hasAuthorship W2313174911A5020516419 @default.
- W2313174911 hasAuthorship W2313174911A5034871851 @default.
- W2313174911 hasAuthorship W2313174911A5043705577 @default.
- W2313174911 hasAuthorship W2313174911A5086542581 @default.
- W2313174911 hasConcept C126322002 @default.
- W2313174911 hasConcept C185592680 @default.
- W2313174911 hasConcept C190283241 @default.
- W2313174911 hasConcept C203014093 @default.
- W2313174911 hasConcept C2777178219 @default.
- W2313174911 hasConcept C2777575956 @default.
- W2313174911 hasConcept C553184892 @default.
- W2313174911 hasConcept C55493867 @default.
- W2313174911 hasConcept C71924100 @default.
- W2313174911 hasConcept C88634738 @default.
- W2313174911 hasConcept C98274493 @default.
- W2313174911 hasConceptScore W2313174911C126322002 @default.
- W2313174911 hasConceptScore W2313174911C185592680 @default.
- W2313174911 hasConceptScore W2313174911C190283241 @default.
- W2313174911 hasConceptScore W2313174911C203014093 @default.
- W2313174911 hasConceptScore W2313174911C2777178219 @default.
- W2313174911 hasConceptScore W2313174911C2777575956 @default.
- W2313174911 hasConceptScore W2313174911C553184892 @default.
- W2313174911 hasConceptScore W2313174911C55493867 @default.
- W2313174911 hasConceptScore W2313174911C71924100 @default.
- W2313174911 hasConceptScore W2313174911C88634738 @default.
- W2313174911 hasConceptScore W2313174911C98274493 @default.
- W2313174911 hasIssue "Suppl 2" @default.
- W2313174911 hasLocation W23131749111 @default.
- W2313174911 hasOpenAccess W2313174911 @default.
- W2313174911 hasPrimaryLocation W23131749111 @default.
- W2313174911 hasRelatedWork W1589118360 @default.
- W2313174911 hasRelatedWork W1972404131 @default.
- W2313174911 hasRelatedWork W2349578600 @default.
- W2313174911 hasRelatedWork W2365320098 @default.
- W2313174911 hasRelatedWork W2367361699 @default.
- W2313174911 hasRelatedWork W2367894058 @default.
- W2313174911 hasRelatedWork W2368062056 @default.
- W2313174911 hasRelatedWork W2381275445 @default.
- W2313174911 hasRelatedWork W2391870033 @default.
- W2313174911 hasRelatedWork W2393309390 @default.
- W2313174911 hasVolume "73" @default.
- W2313174911 isParatext "false" @default.
- W2313174911 isRetracted "false" @default.
- W2313174911 magId "2313174911" @default.
- W2313174911 workType "article" @default.